Wynholds Kristin 4
4 · Better Therapeutics, Inc. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Wynholds Kristin
Chief Product Officer
Transactions
- Award
Common Stock
2022-05-31$1.54/sh+5,023$7,728→ 95,038 total - Award
Common Stock
2022-11-30$1.24/sh+3,781$4,692→ 98,819 total
Footnotes (1)
- [F1]These shares were acquired under the Better Therapeutics, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).